ISABEL M. R.
- Country
- Spain
- Department
- #2201: Servicio de Hemato-Oncología Pediátrica
Research Overview
- Safety and Efficacy of Asciminib, Blinatumomab, and Combination Therapy in Pediatric and Young Adult Patients with Relapsed/Refractory BCR::ABL1+ or Ph-like ALL
- Asciminib in Pediatric Philadelphia-Positive Chronic Myeloid Leukemia in Chronic Phase With or Without T315I Mutation: Phase II Safety and Efficacy Study
- Evaluation of Cisplatin-Based Regimens and Drug Combinations in Pediatric Hepatoblastoma and Hepatocellular Carcinoma: A Multicenter Clinical Trial
Data & Insights
Has run more than one trial at 20 of 102 partner sites.
Specializations
Pediatric Liver Cancer Research
This investigator specializes in the study of primary liver malignancies in children, with particular focus on hepatoblastoma and hepatocellular carcinoma.
- Risk-stratified treatment approaches
- Pediatric liver tumor management
- Clinical outcomes assessment
The research encompasses therapeutic strategies for various risk categories of pediatric liver cancers.
Therapeutic Innovation
The investigator explores innovative treatment combinations including targeted therapies and chemotherapy protocols for pediatric liver cancers.
- Multi-agent chemotherapy development
- Treatment optimization studies
- Novel drug combinations
Their work includes evaluation of treatment duration and intensity based on patient response.
Clinical Research Focus
The investigator's work centers on developing personalized treatment strategies for pediatric liver cancer patients.
- Biological sample analysis
- Toxicity monitoring
- Treatment response assessment
Their research includes comprehensive evaluation of therapeutic outcomes across different treatment protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.